| Professional Services Industry | Industrials Sector | Dr. Niels Pörksen CEO | WSE Exchange | PLVOXEL00014 ISIN |
| Poland Country | 323 Employees | 24 Sep 2025 Last Dividend | - Last Split | - IPO Date |
Voxel S.A. stands at the forefront of the medical technology industry with its pioneering efforts in advanced diagnostic imaging services. With a reputation for innovation on an international scale, Voxel S.A. has cemented its role as a key player in enhancing the diagnostic processes of medical institutions worldwide. The company's offerings are crucial for the accurate diagnosis and treatment planning that underpin effective patient care. Operating in both the public and private healthcare sectors, Voxel S.A. ensures that medical institutions are equipped with the latest in imaging technology, paired with expert analysis, thus improving both diagnostic accuracy and healthcare efficiency. This commitment to integrating cutting-edge technology with precision in medical imaging places Voxel S.A. as an indispensable part of the evolving healthcare landscape, addressing the growing demand for high-quality diagnostic services.
Magnetic Resonance Imaging (MRI) scans offered by Voxel S.A. utilize powerful magnetic fields and radio waves to produce detailed images of the inside of the body. These scans are crucial for diagnosing a variety of conditions, from tumors and strokes to musculoskeletal injuries, ensuring clinicians have a comprehensive understanding of a patient's condition for accurate treatment planning.
Computed Tomography (CT) scans, another specialty of Voxel S.A., provide cross-sectional images of the body using computer-processed combinations of many X-ray measurements taken from different angles. This technology is instrumental in diagnosing diseases and injuries across a wide spectrum, including detecting cancers, examining traumatic injuries, and guiding surgical procedures.
Positron Emission Tomography (PET) scans are essential for revealing how tissues and organs are functioning, significantly aiding in the diagnosis of cancer, heart disease, and brain disorders. By using radioactive substances to highlight areas of chemical or metabolic activity, PET scans offered by Voxel S.A. play a critical role in early disease detection and monitoring the effectiveness of treatment regimens.